Last reviewed · How we verify
Acute bacterial peritonitis
Approved treatments
- Ciprofloxacine · Poitiers University Hospital
- Invanz · Merck & Co.
Invanz works by inhibiting bacterial cell wall synthesis, ultimately leading to bacterial cell death. - Noroxin
- Floxin
- Cipro · Bayer AG
- Ofloxacine · Assistance Publique - Hôpitaux de Paris
Competitive intelligence
For the full treatment-landscape CI brief — marketed leaders side-by-side, pipeline by phase, recent regulatory actions, sponsor landscape:
- Acute bacterial peritonitis patent landscape — cliff calendar, originator estates, attackable patents
- Acute bacterial peritonitis treatment landscape brief
- Acute bacterial peritonitis treatment updates RSS
Frequently asked questions about Acute bacterial peritonitis
What drugs treat Acute bacterial peritonitis?
Tracked treatments include Ciprofloxacine, Invanz, Noroxin, Floxin, Cipro, Ofloxacine.
What is the treatment for Acute bacterial peritonitis?
Standard treatment for Acute bacterial peritonitis includes Ciprofloxacine, Invanz, Noroxin, Floxin, Cipro. See the treatment landscape page for first-line, second-line and salvage options.
Related
- Treatment landscape: Acute bacterial peritonitis patent cliff · Acute bacterial peritonitis CI report
- Treatment: Ciprofloxacine · Poitiers University Hospital
- Treatment: Invanz · Merck & Co.
- Treatment: Noroxin
- Treatment: Floxin
- Treatment: Cipro · Bayer AG
- All diseases: Browse the disease index · Disease landscape hub
Primary sources · FDA · ClinicalTrials.gov · EMA · SEC EDGAR · ChEMBL · Wikidata · full sourcing